Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division Sort descending
  • Business
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Sort descending Business Functional Area Erscheinungsdatum
Engagement Services Senior Expert (Japanese Speaker) Selangor Malaysia People & Organization CTS Humanressourcen Sep 04, 2024
External Workforce Management Process Specialist Prague Tschechische Republik People & Organization CTS Humanressourcen Okt 15, 2024
H2R Services Expert Moscow (City) Russische Foed. People & Organization CTS Humanressourcen Okt 15, 2024
External Workforce Management Process and Compliance Lead Prague Tschechische Republik People & Organization CTS Humanressourcen Okt 16, 2024
Human Resources Services Expert with German Prague Tschechische Republik People & Organization CTS Humanressourcen Okt 16, 2024
H2R Services Expert Moscow (City) Russische Foed. People & Organization CTS Humanressourcen Okt 16, 2024
Global Benchmarking Process Expert Hyderabad (Office) Indien People & Organization CTS Humanressourcen Okt 23, 2024
Senior Manager Vendor Management Hyderabad (Office) Indien People & Organization CTS Beschaffung Okt 24, 2024
Talent Acquisition Business Partner Home Worker Vereinigtes Königreich People & Organization CTS Humanressourcen Okt 24, 2024
H2R Services Specialist Hyderabad (Office) Indien People & Organization CTS Humanressourcen Okt 24, 2024
Human Resources Expert (Temporary 12 moths) INSURGENTES Mexiko People & Organization CTS Humanressourcen Okt 24, 2024
HR Operations Specialist (Time Services Delivery) with Czech Prague Tschechische Republik People & Organization CTS Humanressourcen Okt 21, 2024
Global Head – Learner Experience Enablement Prague Tschechische Republik People & Organization CTS Humanressourcen Okt 21, 2024
Time Services Expert – US & Canada INSURGENTES Mexiko People & Organization CTS Humanressourcen Okt 22, 2024
Engagement Services Expert (Japanese speaker) Selangor Malaysia People & Organization CTS Humanressourcen Okt 22, 2024
Talent Acquisition Coordinator INSURGENTES Mexiko People & Organization CTS Humanressourcen Okt 22, 2024
P&O Manager,People Partner Shanghai (Shanghai) China People & Organization Innovative Medicines Humanressourcen Sep 03, 2024
TA Strategy Director, Immunology East Hanover USA Strategy & Growth Innovative Medicines BD&L & Strategic Planning Jun 11, 2024
Exec. Director, Therapeutic Area Strategy, Cardiovascular Cambridge (USA) USA Strategy & Growth Innovative Medicines BD&L & Strategic Planning Okt 08, 2024
Allergy-Territory Account Specialist – Green Bay, WI – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Aug 27, 2024
Intake Specialist INSURGENTES Mexiko US Innovative Medicines Einrichtungen und Verwaltung Sep 02, 2024
Director, Process Effectiveness & Reporting East Hanover USA US Innovative Medicines Marketing Sep 03, 2024
Medical Science Liaison Onc Prostate Radioligand Therapies DFW or North Remote USA US Innovative Medicines Research & Development Jun 05, 2024
Associate Director, Access & Reimbursement RLT, Seattle, WA - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Jul 19, 2024
Medical Science Liaison Allergy / Derm MN, WI, ND, SD Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development Apr 25, 2024
Oncology Specialist - RLT- Portland- Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Apr 29, 2024
ABL - RLT Field Sales (USA) USA US Innovative Medicines Der Umsatz Apr 30, 2024
Allergy- Territory Account Specialist – Akron, OH– Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 10, 2024
Allergy-Territory Account Specialist – Flint, MI – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 10, 2024
Allergy-Territory Account Specialist – Ann Arbor, MI – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 10, 2024
Allergy Territory Account Specialist - Chicago, IL (South) - Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 11, 2024
Allergy-Territory Account Specialist – Toldeo, OH – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 13, 2024
349145BR - Director, Channel Enablement and Optimization Governance East Hanover USA US Innovative Medicines Marketing Sep 13, 2024
Cardiovascular Institutional Sales Specialist– Boston – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 17, 2024
Allergy Territory Account Specialist - Los Angeles, CA (East) - Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 23, 2024
Allergy Territory Account Specialist - Chicago, IL (North) - Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 23, 2024
Allergy-Territory Account Specialist – Wichita, KS – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 24, 2024
AD, Patient Support Center - Program Monitoring Arizona USA US Innovative Medicines Quality Okt 04, 2024
Cardiovascular Territory Account Specialist (Part-Time) – Bakersfield, CA – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Okt 04, 2024
Associate Director, Curriculum Design East Hanover USA US Innovative Medicines Der Umsatz Okt 04, 2024
Allergy-Territory Account Specialist – Fort Wayne, IN – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 25, 2024
Allergy- Territory Account Specialist – San Francisco, CA – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 27, 2024
Allergy- Territory Account Specialist – Detroit, MI – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Sep 30, 2024
Director Account Management and Pricing Strategy - Remote Remote Position (USA) USA US Innovative Medicines Market Access Okt 08, 2024
Medical Science Liaison Onc Prostate Radioligand Therapies Michigan Territory Field Non-Sales (USA) USA US Innovative Medicines Research & Development Okt 09, 2024
Associate Director, Digital Analytics - HQ based - East Hanover, NJ East Hanover USA US Innovative Medicines Marketing Okt 09, 2024
Dermatology Territory Account Specialist – Boston South – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Okt 10, 2024
Dermatology Territory Account Specialist – Portland ME – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Okt 10, 2024
RLT Customer Support INSURGENTES Mexiko US Innovative Medicines Technical Operations Okt 10, 2024
Rheumatology Territory Account Specialist – Houston West – Remote Field Sales (USA) USA US Innovative Medicines Der Umsatz Okt 10, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.